Submitted by kzahs_258301 on Tue, 05/22/2018 - 5:46pm NCT03493282 CT1812 United States Friday, April 20, 2018 – Tuesday, December 31, 2019 21 Phase 1/2 Alzheimer's Disease Tuesday, May 22, 2018 Cognition Therapeutics Inc. Comments No Available Comments Make a Comment To make a comment you must login or register.
Submitted by kzahs_258301 on
Submitted by kzahs_258301 on
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.